FDA Approves Unknown Drug — SANDOZ

Sandoz today received FDA approval for the unspecified substance designated under NDA020883 on June 30, 2000; although the specific therapeutic attribute remains unidentified in the provided data, regulatory clearance typically signals potential market entry or repurposing opportunities for the manufacturer.